COMPL-AI Identifies Critical Compliance Gaps in DeepSeek Models Under the EU AI Act
4.2.2025 10:44:00 CET | Business Wire | Press Release
COMPL-AI, the first evaluation framework for Generative AI models under the EU AI Act, has flagged critical compliance gaps in DeepSeek's distilled models. While these models excel in toxicity prevention, they fall short in key regulatory areas, including cybersecurity vulnerabilities and bias mitigation challenges, raising concerns about their readiness for production use by enterprises.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250204744295/en/
Check the compliance readiness of DeepSeek distilled models at compl-ai.org (Graphic: Business Wire)
Developed by ETH Zurich, INSAIT, and LatticeFlow AI, COMPL-AI is the first compliance-centered framework that translates regulatory requirements into actionable technical checks. It provides independent, systematic evaluations of public foundation models from leading AI organizations, including OpenAI, Meta, Google, Anthropic, Mistral AI, and Alibaba, helping companies assess their compliance readiness under the EU AI Act.
Key Insights from DeepSeek´s Compliance Evaluation
Leveraging COMPL-AI, LatticeFlow AI assessed the EU AI Act compliance readiness of two DeepSeek distilled models:
- DeepSeek R1 8B (based on Meta’s Llama 3.1 8B)
- DeepSeek R1 14B (built on Alibaba’s Qwen 2.5 14B)
The evaluation benchmarked those DeepSeek models against the EU AI Act’s regulatory principles, comparing their performance not only to their base models but also to models from OpenAI, Google, Anthropic, and Mistral AI, all featured on the COMPL-AI leaderboard.
Key findings are:
- Cybersecurity Gaps: The evaluated DeepSeek models rank lowest in the leaderboard for cybersecurity and show increased risks in goal hijacking and prompt leakage protection in comparison to their base models.
- Increased Bias: DeepSeek models rank below average in the leaderboard for bias and show significantly higher bias than their base models.
- Good Toxicity Control: The evaluated DeepSeek models perform well in toxicity mitigation, outperforming their base models.
(Full DeepSeek evaluation results are available at https://compl-ai.org).
“As corporate AI governance requirements tighten, enterprises need to bridge internal AI governance and external compliance with technical evaluations to assess risks and ensure their AI systems can be safely deployed for commercial use,” said Dr. Petar Tsankov, CEO and Co-founder of LatticeFlow AI. “Our evaluation of DeepSeek models underscores a growing challenge: while progress has been made in improving capabilities and reducing inference costs, one cannot ignore critical gaps in key areas that directly impact business risks – cybersecurity, bias, and censorship. With COMPL-AI, we commit to serving society and businesses with a comprehensive, technical, transparent approach to assessing and mitigating AI risks.”
About COMPL-AI
COMPL-AI offers the first technical interpretation of the EU AI Act and an open-source framework leveraging 27 state-of-the-art benchmarks for evaluating LLMs against regulatory requirements. It has already been used to assess models from OpenAI, Meta, Google, Anthropic, and Alibaba, providing unprecedented insights into their compliance readiness.
About LatticeFlow AI
LatticeFlow AI enables enterprises to ensure AI systems are performant, trustworthy, and compliant. As a pioneer in AI evaluations, LatticeFlow AI has developed COMPL-AI – the world’s first EU AI Act compliance evaluation framework, developed in partnership with ETH Zurich and INSAIT. Globally recognized for its impact, LatticeFlow AI has received the US Army Global Award and has been named on CB Insights’ AI100 list of the world’s most innovative AI companies.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250204744295/en/
Contacts
Media Enquiries:
Gloria Fernandez, Marketing Director
media@latticeflow.ai
LatticeFlow AI
(c) 2024 Business Wire, Inc., All rights reserved.
Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Mobix Labs Signs Definitive Agreement to Acquire Vision Aerial, Accelerating Global Drone Platform for National Security and Aerial Intelligence24.7.2026 13:00:00 CEST | Press Release
Mobix Labs, Inc. (Nasdaq: MOBX) today announced that it has signed a definitive agreement to acquire Vision Aerial, Inc., a U.S.-based designer and manufacturer of American-built, National Defense Authorization Act (NDAA)-compliant unmanned aerial systems. The definitive agreement moves the transaction beyond the previously announced letter of intent and represents a major step toward closing an acquisition that would expand Mobix Labs into one of the world’s most important technology growth markets: secure drones, autonomous aerial systems and aerial intelligence for national security, critical infrastructure, energy, public safety, industrial inspection and government operations. Vision Aerial’s customers and end-users include the U.S. Air Force, U.S. Navy, government agencies, energy and utility operators, research institutions and other organizations requiring performance, reliability and trusted supply chains. Its drones support national security and public-safety operations, sear
Enhertu ® Plus Pertuzumab Recommended for Approval in the EU by CHMP as First-Line Treatment for Patients with HER2 Positive Metastatic Breast Cancer24.7.2026 13:00:00 CEST | Press Release
Enhertu® (trastuzumab deruxtecan) in combination with pertuzumab has been recommended for approval in the European Union (EU) for the first-line treatment of adult patients with unresectable or metastatic HER2 positive (immunohistochemistry [IHC] 3+ or in-situ hybridization [ISH]+) breast cancer. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from theDESTINY-Breast09 phase 3 trialpresented at the 2025 American Society of Clinical Oncology Annual Meeting and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DESTI
SLB Announces Second-Quarter 2026 Results24.7.2026 12:50:00 CEST | Press Release
SLB (NYSE: SLB) today announced results for the second-quarter 2026. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260722694386/en/ The exterior of the SLB headquarters in Houston, Texas. Second-Quarter Results(Stated in millions, except per share amounts)Three Months EndedChangeJun. 30, 2026Mar. 31, 2026Jun. 30, 2025SequentialYear-on-yearRevenue $8,972 $8,721 $8,546 3% 5% Income before taxes - GAAP basis $1,018 $956 $1,285 6% -21% Income before taxes margin - GAAP basis 11.3% 11.0% 15.0% 38 bps -369 bps Net income attributable to SLB - GAAP basis $786 $752 $1,014 5% -22% Diluted EPS - GAAP basis $0.52 $0.50 $0.74 4% -30% Adjusted EBITDA* $1,899 $1,773 $2,051 7% -7% Adjusted EBITDA margin* 21.2% 20.3% 24.0% 83 bps -284 bps Pretax segment operating income* $1,404 $1,321 $1,584 6% -11% Pretax segment operating margin* 15.6% 15.2% 18.5% 49 bps -289 bps Net income attributable to SLB, excluding charges & credits* $833 $783 $1,0
NIQ Expands GenAI Capabilities Across gfknewron, Turning Trusted Intelligence into Decisions Faster24.7.2026 12:30:00 CEST | Press Release
NIQ (NYSE: NIQ), a leader in consumer intelligence, today announced the expansion of AI-powered Smart Insights across its gfknewron® platform. By bringing together markets and categories into a single view, gfknewron enables businesses to transform complex market, consumer and supply chain data into clear, actionable intelligence quickly. The latest enhancements help users identify trends, opportunities and performance drivers more quickly, reducing the time required to analyze large datasets and accelerating confident decision-making across teams. As brands and retailers face growing pressure to respond quickly to changing consumer behavior and market dynamics, the ability to unlock meaningful insights from increasingly rich datasets has become a significant competitive advantage. As AI is only as effective as the intelligence behind it, Smart Insights helps businesses realize the full value of NIQ's trusted market intelligence by automatically surfacing the trends, opportunities and
Thales to Strengthen Romania’s Airspace Protection With Twelve Ground Master 200 MM/A Radars24.7.2026 10:05:00 CEST | Press Release
In a context of growing collaboration between European nations to bolster collective security, the Romanian General Directorate for Armaments has just signed a landmark agreement with France’s Direction Générale de l’Armement (DGA) to acquire twelve Thales Ground Master 200 Multi-Mission All-in-one (GM200 MM/A) radars. This government-to-government agreement, funded under the European Union’s SAFE programme, underlines the high level of partnership between France and Romania. The first delivery is expected in 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260724603527/en/ The Romanian General Directorate for Armaments and the French Direction Générale de l’Armement (DGA – the French defence procurement agency) have signed an agreement to supply twelve Thales GM200 Multi-Mission All-in-one (GM200MM/A) radars to protect the Romanian airspace. The GM200 MM/A is a combat-proven medium-range 4D AESA radar, already deployed
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom